XML 56 R50.htm IDEA: XBRL DOCUMENT v3.19.3
REVENUE (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Aug. 31, 2019
Sep. 30, 2019
Sep. 30, 2018
Jun. 30, 2019
Sep. 30, 2019
Sep. 30, 2018
Revenue            
Revenue   $ 1,301,197 $ 1,373,334   $ 3,845,629 $ 4,131,896
Manufacturer's rebates earned on total gross profit (in percent)   (5.50%) 22.10%   5.90% 17.20%
Rebate adjustments   $ 9,000        
Rebate penalty $ 9,000     $ 6,000    
Accrual for litigation relating to rebate dispute with a terminated customer   3,900     $ 3,900  
Inter-segment eliminations            
Revenue            
Revenue   (24,751) $ (8,897)   (52,683) $ (17,275)
Specialty            
Revenue            
Revenue   1,243,448 1,212,298   3,627,582 3,599,023
PBM            
Revenue            
Revenue   82,500 169,933   270,730 550,148
Oncology | Specialty            
Revenue            
Revenue   718,859 701,206   2,123,574 2,094,394
Specialty infusion | Specialty            
Revenue            
Revenue   209,767 178,890   580,254 525,857
Immunology | Specialty            
Revenue            
Revenue   135,740 135,397   412,268 413,948
Other | Specialty            
Revenue            
Revenue   179,082 196,805   511,486 564,824
Retail networks | PBM            
Revenue            
Revenue   48,604 126,082   173,800 417,370
Specialty pharmacy | PBM            
Revenue            
Revenue   23,156 22,470   57,323 67,784
Mail order | PBM            
Revenue            
Revenue   7,976 16,019   30,758 50,029
Other | PBM            
Revenue            
Revenue   $ 2,764 $ 5,362   $ 8,849 $ 14,965